Drugs / Live Japanese encephalitis vaccine SA 14-14-2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00249769 | Nov 2005 → May 2006 | Japanese encephalitis | PATH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live Japanese encephalitis vaccine SA 14-14-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00249769 ↗ |
| Known as | LJEV | “Live Japanese encephalitis vaccine SA 14-14-2 (LJEV) is lyophilized powder that looks like a milky-white crisp cake.” NCT00249769 ↗ |
| Modality | Vaccine | “An effective, live, attenuated JE vaccine (LJEV) is available;” PMID 18394765 ↗ Mar 2008 |